Synergy of piracetam and aminalon in the cerebroprotective effect of olatropyl
Journal Title: Медичні перспективи - Year 2018, Vol 23, Issue 3
Abstract
Optimization of pharmacotherapy of neurological and psychosomatic diseases led to the creation of com¬bined medicines containing two or more components with different mechanisms of action, differently affecting the pathogenesis and clinical manifestations of specific forms of pathology. Combined drugs that help normalize the central regulatory mechanisms of the development of somatic pathology, improve brain metabolism and hemodynamics, stabilize the cortical-subcortical relationships, the disorders of which lie at the base of many forms of neurological and psychosomatic pathology have been particularly popular in recent years. In this article we propose options for opti¬mizing nootropic therapy with olatropyl, which is a combination of two "true" nootropics - gamma-aminobutyric acid (aminalone) and piracetam in one drug form. Such a combination allows one-stage implementation of a complex of multifaceted and diverse effects on the central nervous system characteristic of both piracetam and aminalone, but achieved through fundamentally different mechanisms of action of these agents. The mechanism of action of olatropil demonstrates the pronounced synergism of the monocomponents of the preparation. This combination allows to reduce the therapeutic dosages of each of the active substances by 2 times, which, in turn, leads to a decrease in the incidence and severity of possible side effects; leveling the exciting effect of piracetam and providing higher safety and efficacy. The drug is an effective tool for the therapy of various forms of cerebrovascular pathology, improving cognitive functions, mental activity, psychoemotional status, autonomic functions, favorably affecting the quality of life of patients. The uniqueness of the mechanism of action of olatropil, consisting in the occurrence of the fact of pharmacodynamic synergy in the combined use of piracetam and aminalone in a single dosage form, contributes to the enhancement of positive pharmacological effects and the leveling of a number of negative elements of pharmacodynamics of preparation constituents.
Authors and Affiliations
V. I. Mamchur, S. N. Dronov
Keywords
Related Articles
- EP ID EP439167
- DOI 10.26641/2307-0404.2018.3.147945
- Views 98
- Downloads 0
Dnipro Pharmacology School: a 100 years’ journey (to the centenial of the department of pharmacology and clinical pharmacology of Dnipropetrovsk medical academy). Part I: 1918-1943.
The article presents analysis of the main historical stages of the establishing and development of the scientific school of pharmacology of the SE "Dnipropetrovsk Medical Academy of Health Ministry of Ukraine" for a 100-...
Possibilities of magnet-resonance tomography usage while examining patients with reccurent genital prolapse.
Complex problem of establishing a diagnosis and choosing optimal treatment for patients with recurrent genital prolapse calls for improving preoperative clinical examination of these patients. Relapse necessitates better...
Factors of cardiovascular risk and cognitive dysfunction in patients with controlled hypertension
According to the survey of 68 patients with arterial hypertension stage II, 1-2 degrees, controlled on the background of antihypertensive therapy, cardiovascular risk, severity of cognitive impairment were analyzed. Inst...
Methodological approaches to estimation of teenagers' health
On the basis of International classification of functioning, limitations of vital activity and health, model of estimation of teenagers' health considering these changes from positions of functioning of the organism and...
Оксидантно-антиоксидантний баланс у крові і тканинах ясен щурів з експериментальним гастродуоденітом
С целью изучения начальных изменений в тканях пародонта при заболеваниях верхних отделов желудочно-кишечного тракта было про¬ведено исследование оксидантно-антиоксидантного баланса в тканях дёсен и сыворотке крови крыс...